Phar­maceu­ti­cal pro­duc­tion and qua­li­ty teams ope­ra­te under con­stant pres­su­re to main­tain flaw­less stan­dards. Yet, many of the pro­ces­ses desi­gned to catch errors still rely on manu­al inspec­tion, rule-based sys­tems, and paper-based docu­men­ta­ti­on. That is incre­asing­ly dif­fi­cult to sca­le.

We are streng­thening our Com­pu­ter Visi­on capa­bi­li­ties with two new spe­cia­lists who bring deep expe­ri­ence buil­ding inspec­tion-focu­sed com­pu­ter visi­on models for phar­ma manu­fac­tu­ring. This is a good moment to out­line what modern Com­pu­ter Visi­on can do for your ope­ra­ti­ons.

Smarter visual inspection on the production line

AI-based visi­on models learn what nor­mal looks like and flag any­thing that devia­tes, not just pre­de­fi­ned defect types. Label­ling errors, pack­a­ging irre­gu­la­ri­ties, pro­duct dama­ge, and unu­su­al equip­ment beha­viour beco­me visi­ble in real time, direct­ly from exis­ting line came­ras.

Detecting what hasn’t been seen before

Rather than wai­ting for defects to accu­mu­la­te, anoma­ly detec­tion sys­tems flag ear­ly visu­al signals of emer­ging issues befo­re they beco­me qua­li­ty events. This shifts pro­duc­tion over­sight from peri­odic manu­al review to con­ti­nuous, auto­ma­ted moni­to­ring.

Unlocking data locked in GMP documents

AI docu­ment reco­gni­ti­on extra­cts struc­tu­red data from paper batch records, log­books, and check­lists auto­ma­ti­cal­ly. This redu­ces manu­al tran­scrip­ti­on effort, flag­ging miss­ing ent­ries, and impro­ving inspec­tion rea­di­ness.

The­se capa­bi­li­ties are part of the Stat­Soft Phar­ma Suite, desi­gned to inte­gra­te with exis­ting pro­duc­tion infra­struc­tu­re. If you are eva­lua­ting whe­re Com­pu­ter Visi­on fits in your qua­li­ty or manu­fac­tu­ring stra­tegy, we would wel­co­me the con­ver­sa­ti­on.